Remarkably, the combined transfer of memory CD8+ and CD4+ T cells synergized to better control tumor growth in the NDV-GP-treated group than in monotransfer of memory CD8+ or CD4+ T cells (Fig. 3d). Here, CD8A is linked to neoplasm.